Home » Topics » Regulatory

Regulatory
RSS

Nicox announces FDA approval of Vyzulta, recaps pipeline progress

Nov. 3, 2017

Calquence approved and available to order in U.S. for mantle cell lymphoma

Nov. 2, 2017

Ebola vaccine approved in China

Oct. 26, 2017

FDA approves CAR T therapy Yescarta for adults with relapsed or refractory large B-cell lymphoma

Oct. 19, 2017

Health Canada first to approve Shingrix

Oct. 16, 2017

SKYZoster approved in South Korea

Oct. 16, 2017

FDA approves Zilretta for osteoarthritis knee pain

Oct. 9, 2017

Lutathera approved in Europe

Oct. 2, 2017

FDA approves Verzenio in breast cancer

Sep. 29, 2017

Japanese approval for Cedarcure SLIT for Japanese cedar allergy

Sep. 27, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...